cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Orasure Technologies Inc
8 own
13 watching
Current Price
$5.52
$-0.25
(-4.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
526.76M
52-Week High
52-Week High
8.45000
52-Week Low
52-Week Low
4.38000
Average Volume
Average Volume
0.42M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
144.6438
iconMarket Capitalization526.76M
icon52-Week High8.45000
icon52-Week Low4.38000
iconAverage Volume0.42M
iconDividend Yield--
iconP/E Ratio144.6438
What does the Orasure Technologies Inc do?
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV1/2, OraQuick HIV self-test, OraQuick HCV, OraQuick In-Home HIV test, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene GUT, OMNIgene SPUTUM, PrepIT MAX, OMNIgene VAGINAL, OMNIgene ORAL, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, pharmacogenomics, personalized medicine, microbiome and animal genetics, and academic research markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, retail pharmacies, mass merchandisers, and consumers. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
Read More
How much money does Orasure Technologies Inc make?
News & Events about Orasure Technologies Inc.
PR Newswire
1 year ago
Thinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox? Thinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox? PR Newswire NEW YORK, Feb. 15, 2023 NEW YORK, Feb...
Benzinga
1 year ago
OraSure Technologies (NASDAQ:OSUR) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that OraSure Technologies will report an earnings per share (EPS) of $-0.04. read more...
Globe Newswire
1 year ago
FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha1- Antripsyn Deficiency (Alpha-1) in U.S. Adult Population BETHLEHEM, Pa., Nov. 03, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic ...
PR Newswire
1 year ago
Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies? Thinking about buying stock in Acumen Pharmaceuticals, Prothena Corp, Anavex Life Sciences, Ocugen, or OraSure Technologies? PR Newswire NEW YORK, Sept. 28, 2022 NEW YORK...
Ticker Report
1 year ago
SG Americas Securities LLC trimmed its holdings in shares of OraSure Technologies, Inc. (NASDAQ:OSUR Get Rating) by 9.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 78,510 shares of the medical instruments ...
Frequently Asked Questions
Frequently Asked Questions
What is Orasure Technologies Inc share price today?
plus_minus_icon
Can Indians buy Orasure Technologies Inc shares?
plus_minus_icon
How can I buy Orasure Technologies Inc shares from India?
plus_minus_icon
Can Fractional shares of Orasure Technologies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Orasure Technologies Inc stocks?
plus_minus_icon
What is today’s traded volume of Orasure Technologies Inc?
plus_minus_icon
What is today’s market capitalisation of Orasure Technologies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Orasure Technologies Inc?
plus_minus_icon
What percentage is Orasure Technologies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Orasure Technologies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.52
$-0.25
(-4.33%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00